Reagenti e strumenti per immunologia, biologia cellulare e biologia molecolare
 

MyBiosource

 
SARS-CoV-2 - Acalabrutinib - Candidats thérapeutiques

SARS-CoV-2 - Acalabrutinib - Candidats thérapeutiques

Risultati della ricerca : 23 prodotto(i) trovato(i)

Limita la ricerca :

RUOCE / IVD
  • Unconjugated 18
  • Inhibitor/Antagonist/Agonist 15
  • Biochemicals 8
APPLICARE I FILTRI
REINIZIALIZZARE


Cat#
Descrizione
Cond.
Priced
MBS578493-25mg
Acalabrutinib
 25mg 
MBS578493-200mg
Acalabrutinib
 200mg 
MBS578493-5x500mg
Acalabrutinib
 5x500mg 
MBS578493-500mg
Acalabrutinib
 500mg 
MBS3601758-10mg
Acalabrutinib
 10mg 
MBS3601758-200mg
Acalabrutinib
 200mg 
MBS3601758-50mg
Acalabrutinib
 50mg 
MBS578493-100mg
Acalabrutinib
 100mg 
MBS578493-50mg
Acalabrutinib
 50mg 
MBS578493
Acalabrutinib
 Onrequest 
MBS3601758-25mg
Acalabrutinib
 25mg 
MBS3601758-500mg
Acalabrutinib
 500mg 
MBS578493-10mg
Acalabrutinib
 10mg 
MBS578493-5mg
Acalabrutinib
 5mg 
MBS3601758-100mg
Acalabrutinib
 100mg 
MBS3601758-5x500mg
Acalabrutinib
 5x500mg 
MBS3601758-5mg
Acalabrutinib
 5mg 
MBS130626-100mg
Acalabrutinib (ACP-196)
 100mg 
MBS130626-500mg
Acalabrutinib (ACP-196)
 500mg 
MBS384117-10mg
ACP-196 (Acalabrutinib)
 10mg 
    ‹
    ›